World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
139
Citations
65996
World Ranking
1769
National Ranking
1010

Neal Rosen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Neal Rosen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 401 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Neal Rosen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Neal Rosen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 139 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Neal Rosen is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on molecular biology, oncology, and cancer research, with a significant emphasis on biochemistry, genetics, and molecular biology as broader fields of study.

Their work covers specialized subfields such as molecular biology, oncology, pulmonary and respiratory medicine, and immunology. Within these areas, Neal Rosen concentrates on topics including melanoma and MAPK pathways, PI3K/AKT/mTOR signaling in cancer, protein degradation and inhibitors, colorectal cancer treatments and studies, cancer genomics and diagnostics, cancer mechanisms and therapy, as well as protein kinase regulation and GTPase signaling.

Neal Rosen has a substantial publication record across various scientific venues. The frequent publication venues include:

  • Cancer Research
  • The Prostate
  • Cancer Discovery
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Cancer Research

Their recent papers illustrate an active engagement with cancer biology and targeted therapies. Some notable publications are:

  • "Targeted drug delivery strategies for precision medicines," 2021, Nature Reviews Materials
  • "EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer," 2020, Cancer Discovery
  • "HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers," 2020, Cancer Discovery
  • "INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors," 2021, Cancer Discovery
  • "Mutant-selective degradation by BRAF-targeting PROTACs," 2021, Nature Communications

Throughout their career, Neal Rosen has collaborated frequently with other researchers. Their most frequent co-authors include:

  • Elisa de Stanchina
  • Rona Yaeger
  • David B. Solit
  • Sandra Misale
  • Radha Mukherjee

Among recognitions, Neal Rosen has been named a member of the Association of American Physicians.

Best Publications

  • mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt

    Kathryn E. O'Reilly;Fredi Rojo;Qing Bai She;David Solit

  • RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

    Poulikos I. Poulikakos;Chao Zhang;Gideon Bollag;Kevan M. Shokat

  • Crystal Structure of an Hsp90–Geldanamycin Complex: Targeting of a Protein Chaperone by an Antitumor Agent

    C E Stebbins;A A Russo;C Schneider;N Rosen

  • RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

    Poulikos I. Poulikakos;Yogindra Persaud;Manickam Janakiraman;Xiangju Kong

  • BRAF mutation predicts sensitivity to MEK inhibition

    David B. Solit;Levi A. Garraway;Levi A. Garraway;Christine A. Pratilas;Ayana Sawai

  • Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer

    Brett S. Carver;Caren Chapinski;John Wongvipat;Haley Hieronymus

  • AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity

    Sarat Chandarlapaty;Ayana Sawai;Maurizio Scaltriti;Vanessa Rodrik-Outmezguine

  • Targeted drug delivery strategies for precision medicines

    Mandana T. Manzari;Yosi Shamay;Hiroto Kiguchi;Hiroto Kiguchi;Neal Rosen;Neal Rosen

  • Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function.

    Andrea D. Basso;Andrea D. Basso;David B. Solit;Gabriela Chiosis;Banabihari Giri

  • Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer

    Rona Yaeger;Walid K. Chatila;Marla D. Lipsyc;Jaclyn F. Hechtman

  • The Tyrosine Kinase Inhibitor ZD1839 ("Iressa") Inhibits HER2-driven Signaling and Suppresses the Growth of HER2-overexpressing Tumor Cells

    Mark M. Moasser;Andrea Basso;Steven D. Averbuch;Neal Rosen

  • Tumor adaptation and resistance to RAF inhibitors.

    Piro Lito;Neal Rosen;David B Solit

  • V600EBRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway

    Christine A. Pratilas;Barry S. Taylor;Barry S. Taylor;Qing Ye;Agnes Viale

  • Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

    Lao H. Saal;Peter Johansson;Karolina Holm;Sofia K. Gruvberger-Saal

  • Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress.

    Paul Workman;Francis Burrows;Len Neckers;Neal Rosen

  • Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas

    Piro Lito;Christine A. Pratilas;Eric W. Joseph;Madhavi Tadi

  • PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer

    V. Serra;M. Scaltriti;L. Prudkin;Pieter Eichhorn

  • Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors.

    Roberto Bianco;Incheol Shin;Christoph A. Ritter;F. Michael Yakes

  • 17-Allylamino-17-demethoxygeldanamycin Induces the Degradation of Androgen Receptor and HER-2/neu and Inhibits the Growth of Prostate Cancer Xenografts

    David B. Solit;Fuzhong F. Zheng;Maria Drobnjak;Pamela N. Münster

  • A Peptidomimetic Inhibitor of Farnesyl:Protein Transferase Blocks the Anchorage-dependent and -independent Growth of Human Tumor Cell Lines

    Laura Sepp-Lorenzino;Zhenping Ma;Elaine Rands;Nancy E. Kohl

Frequent Co-Authors

David B. Solit
David B. Solit Memorial Sloan Kettering Cancer Center
Sarat Chandarlapaty
Sarat Chandarlapaty Memorial Sloan Kettering Cancer Center
José Baselga
José Baselga Memorial Sloan Kettering Cancer Center
Barry S. Taylor
Barry S. Taylor Memorial Sloan Kettering Cancer Center
Michael F. Berger
Michael F. Berger Memorial Sloan Kettering Cancer Center
Gabriela Chiosis
Gabriela Chiosis Memorial Sloan Kettering Cancer Center
Omar Abdel-Wahab
Omar Abdel-Wahab Memorial Sloan Kettering Cancer Center
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Paul B. Chapman
Paul B. Chapman Memorial Sloan Kettering Cancer Center
Samuel J. Danishefsky
Samuel J. Danishefsky Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, there are diverse online degrees and career pathways that could expand your opportunities in healthcare. Many students are now choosing specialized tracks beyond traditional MD programs, including online pmhnp programs to become a Psychiatric-Mental Health Nurse Practitioner. These programs offer flexibility and enable you to focus on mental health—a rising field in healthcare.

For those more interested in the business or management side of healthcare, gaining an online master of health administration is a popular option. These programs help prepare graduates for leadership roles, while still allowing you to study remotely.

If affordability is a priority, you may want to look into affordable mha online programs, making it easier to enter healthcare management without incurring significant debt.

Finally, experienced nurses seeking career advancement can explore the best online bsn to dnp programs. These flexible options let you earn a Doctor of Nursing Practice, positioning you for top clinical or academic roles. Exploring these online programs can help you find a pathway that best matches your interests in the healthcare field.

Best Scientists Citing Neal Rosen

Trending Scientists

Recently Published Articles